CLC-3 and SOX2 Regulate the Cell Cycle in DU145 Cells
Overview
Affiliations
Sex determining region Y-box 2 (SOX2) is a transcription factor that serves a role in numerous different types of malignant cancer. Altered expression of chloride channel proteins has been described in a variety of malignancies. However, the association between SOX2 and chloride channel proteins is not yet fully understood. The present study investigated the association between SOX2 and chloride voltage-gated channel 3 (CLC-3) in prostate cancer. Flow cytometry demonstrated that the inactivation of CLC-3 or SOX2 arrested cell cycle progression in the G/G phase. Furthermore, CLC-3 was observed to bind to SOX2, and vice versa, by co-immunoprecipitation. SOX2 appears to initiate and maintain prostate cancer tumorigenesis, in part, by modulating the cell cycle. These findings indicate the potential of SOX2 and CLC-3 as targets for the development of multi-targeted therapeutics.
The molecular pathogenesis of SOX2 in prostate cancer.
Liu S, Yu H, Zhao Z Discov Oncol. 2025; 16(1):215.
PMID: 39976818 PMC: 11842661. DOI: 10.1007/s12672-025-01972-y.
Huang Y, Wang X, Hu R, Pan G, Lin X Oncol Rep. 2022; 48(4).
PMID: 36069232 PMC: 9478990. DOI: 10.3892/or.2022.8396.
Huang J, Sheng X, Zhuo Z, Xiao D, Wu K, Wan G Cell Prolif. 2021; 55(1):e13173.
PMID: 34952996 PMC: 8780901. DOI: 10.1111/cpr.13173.